Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

KTP 001

Next Previous
X
Search
Drug Profile

KTP 001

Alternative Names: KTP-001; Recombinant human matrix metalloproteinase - KM Biologics/Teijin

Latest Information Update: 21 Jun 2021

Price :

$50 *

Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator University of Yamanashi; Yokohama City Minato Red Cross Hospital
  • Developer KM Biologics; Teijin Pharma
  • Class Matrix metalloproteinases; Recombinant proteins
  • Mechanism of Action Matrix metalloproteinase stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes
  • Available For Licensing Yes

Highest Development Phases

  • Discontinued Intervertebral disc displacement

Most Recent Events

  • 18 Jun 2021 Discontinued - Phase-I/II for Intervertebral disc displacement in USA (Intraspinal) (Teijin Pharma pipeline, June 2021)
  • 31 Jul 2019 KTP 001 is still in phase I/II trials for Intervertebral disc displacement in the US
  • 16 Oct 2018 Teijin Pharma completes a phase I/II trial in Intervertebral disc displacement in USA (NCT01978912)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top